Publications

The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors

Riga MS, Bortolozzi A, Campa L, Artigas F, Celada P,

2016

Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder

Artigas F, Bortolozzi A ,

2016

Subchronic vortioxetine treatment –but not escitalopram– enhances pyramidal neuron activity in the rat prefrontal cortex.

Riga MS, Teruel-Martí V, Sanchez C, Celada P, Artigas F,

2016

Glucocorticoid receptors, brain-derived neurotrophic factor, serotonin and dopamine neurotransmission are associated with interferon-induced depression

Udina M, Navinés R, Egmond E, Oriolo G, Langohr K, Gimenez D, Valdés M, Gómez-Gil E, Grande I, Gratacós M, Kapczinski F, Artigas F, Vieta E, Solà R, Martín-Santos R,

2016

A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.

Nilsson S, Celada P, Fejgin K, Thelin J, Nielsen J, Santana N, Heath C, Larsen P, Nielsen V, Kent B, Robbins T, Saksida L, Stensbøl T, Bastlund J, Bussey T, Artigas F, Didriksen M ,

2016

Behavioral traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms

Mitchell E, Klein S, Argyropoulos KV, Sharma A, Chan RB, Toth JG, Barboza L, Bavley C, Bortolozzi A, Chen Q, Liu B, Ingenito J, Mark W, Dudakov J, Gross S, Di Paolo G, Artigas F, van den Brink M, Toth M ,

2016

Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission

Riga MS, Sánchez C, Celada P, Artigas F,

2016

Long-term and low-dose malathion exposure causes cognitive impairment in adult mice: evidence of hippocampal mitochondrial dysfunction, astrogliosis and apoptotic events

Alessandra Antunes dos Santos, Aline Aita Naime, Jade de Oliveira, Dirleise Colle, Danúbia Bonfanti dos Santos, Mariana Appel Hort, Eduardo Luiz Gasnhar Moreira, Cristina Suñol, Andreza Fabro de Bem and Marcelo Farina,

2016

Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice

Reverte I, Peris-Sampedro F, Basaure P, Campa L, Suñol C, Moreno M, Domingo JL, Colomina MT,

2016

Enhanced Charge Capacity in Iridium Oxide-Graphene Oxide Hybrids.

N.M. Carretero, M.P. Lichtenstein, E. Pérez, S. Sandoval, G. Tobias, C. Suñol, N. Casan-Pastor,

2015

''DEVELOPMENTS IN THE FIELD OF ANTIDEPRESSANTS, WHERE DO WE GO NOW?''

ARTIGAS F,

2015

''COATINGS OF NANOSTRUCTURED PRISTINE GRAPHENE-IROX HYBRIDS FOR NEURAL ELECTRODES: LAYERED STACKING AND THE ROLE OF NON-OXYGENATED GRAPHENE.''

PÉREZ E, LICHTENSTEIN MP, SUÑOL C, CASAÑ-PASTOR N.,

2015

''5-HT2A RECEPTORS ARE INVOLVED IN COGNITIVE BUT NOT ANTIDEPRESSANT EFFECTS OF FLUOXETINE.''

CASTAÑÉ A, KARGIEMAN L, CELADA P, BORTOLOZZI A, ARTIGAS F.,

2015

''THERAPEUTIC ANTIDEPRESSANT POTENTIAL OF A CONJUGATED SIRNA SILENCING THE SEROTONIN TRANSPORTER AFTER INTRANASAL ADMINISTRATION.''

FERRÉS-COY A, GALOFRÉ M, PILAR-CUÉLLAR F, VIDAL R, PAZ V, RUIZ-BRONCHAL E, CAMPA L, PAZOS Á, CASO JR, LEZA JC, ALVARADO G, MONTEFELTRO A, VALDIZÁN EM, ARTIGAS F, BORTOLOZZI A.,

2015

''PUTATIVE ADVERSE OUTCOME PATHWAYS RELEVANT TO NEUROTOXICITY.''

BAL-PRICE A, CROFTON KM, SACHANA M, SHAFER TJ, BEHL M, FORSBY A, HARGREAVES A, LANDESMANN B, LEIN PJ, LOUISSE J, MONNET-TSCHUDI F, PAINI A, ROLAKI A, SCHRATTENHOLZ A, SUÑOL C, VAN THRIEL C, WHELAN M, FRITSCHE E.,

2015

''VORTIOXETINE, A NOVEL ANTIDEPRESSANT WITH MULTIMODAL ACTIVITY: REVIEW OF PRECLINICAL AND CLINICAL DATA.''

SANCHEZ C, ASIN KE, ARTIGAS F.,

2015

''TOXICITY EVALUATION OF NEW AGRICULTURAL FUNGICIDES IN PRIMARY CULTURED CORTICAL NEURONS.''

REGUEIRO J, OLGUÍN N, SIMAL-GÁNDARA J, SUÑOL C.,

2015

''IROX-CARBON NANOTUBE HYBRIDS: A NANOSTRUCTURED MATERIAL FOR ELECTRODES WITH INCREASED CHARGE CAPACITY IN NEURAL SYSTEMS''

NINA M. CARRETERO, MATHIEU P. LICHTENSTEIN, ESTELA PÉREZ, LAURA CABANA, CRISTINA SUÑOL, NIEVES CASAÑ-PASTOR,

2014

''PHYSICAL EXERCISE IMPROVES SYNAPTIC DYSFUNCTION AND RECOVERS THE LOSS OF SURVIVAL FACTORS IN 3XTG-AD MOUSE BRAIN.''

REVILLA S, SUÑOL C, GARCÍA-MESA Y, GIMÉNEZ-LLORT L, SANFELIU C, CRISTÒFOL R,